Income Taxes (Tables)

12 Months Ended

Dec. 31, 2023

Income Tax Disclosure [Abstract]

Schedule of Income before Income Tax, Domestic and Foreign

The domestic and foreign components of loss from continuing operations before income taxes for the years ended December 31, 2023 and 2022 are as follows (in thousands):

	For the Years Ended December 31,
	2023		2022
Domestic	$	(30,679)	$	(13,797)
Foreign	(3,647)		(6,066)
Net Loss, before tax	$	(34,326)	$	(19,863)

Schedule of Components of Income Tax Expense (Benefit)

The income tax provision (benefit) for the years ended December 31, 2023 and 2022 consists of the following (in thousands):

	For the Years Ended December 31,
	2023		2022
Foreign
Current	$	—	$	—
Deferred	(1,168)		(1,456)
U.S. federal
Current	—		(268)
Deferred	(4,544)		(2,123)
State and local
Current	24		86
Deferred	(254)		(123)
	(5,942)		(3,884)
Change in valuation allowance	5,966		3,703
Income Tax Provision (Benefit)	$	24	$	(181)

Schedule of Effective Income Tax Rate Reconciliation

The reconciliation between the U.S. statutory federal income tax rate and the Company’s effective rate for the years ended December 31, 2023 and 2022 is as follows:

	For the Years Ended December 31,
	2023		2022
U.S. federal statutory rate	21.0	%	21.0	%
State income taxes, net of federal benefit	0.6	%	0.5	%
Incentive stock options	(0.1)	%	(0.2)	%
162(m) Compensation Limit	(1.6)	%	—	%
US-Foreign income tax rate difference	0.8	%	1.6	%
Other permanent items	(2.3)	%	(1.6)	%
Provision to return adjustments	0.2	%	1.9	%
Deferred only adjustment	(1.3)	%	(3.7)	%
Change in valuation allowance	(17.4)	%	(18.6)	%
Effective Rate	(0.1)	%	0.9	%

Schedule of Deferred Tax Assets and Liabilities

As of December 31, 2023 and 2022, the Company’s deferred tax assets consisted of the effects of temporary differences attributable to the following:

	As of December 31,
(in 000s)	2023		2022
Deferred Tax Asset
Net operating loss carryovers	$	31,085	$	26,052
Stock based compensation	1,350		1,259
Research credits	—		—
Accrued compensation	24		22
Reserves	263		279
Intangibles	1,750		1,980
Fixed assets	109		149
Unrealized gain	—		—
Capital Research	332		106
Other	2,210		360
Total Deferred Tax Asset	37,123		30,207
Less: valuation allowance	(36,096)		(29,205)
Deferred Tax Asset, Net of Valuation Allowance	$	1,027	$	1,002

	As of December 31,
Deferred Tax Liabilities	2023		2022
Intangible assets	$	(532)	$	(715)
Fixed assets	(99)		(160)
Other	(396)		(127)
Capitalized research	—		—
Total deferred tax liabilities	(1,027)		(1,002)
Net Deferred Tax Asset (Liability)	$	—	$	—